News Search Results
Dec 16, 2025, 10:00 ET Specific Biologics Welcomes Accomplished Biotechnology Leader Dr. Richard Glickman to its Board of Directors
numerous public and private biotechnology companies, including leadership roles as Chair of Aurinia Pharmaceuticals, ESSA Pharma, enGene, and has held board positions at Eupraxia Pharmaceuticals and Cardiome / Correvio Pharma, amongst others, where he helped scale emerging biotechnology companies into globally
More news about: Specific Biologics Inc.
Dec 16, 2025, 10:00 ET Specific Biologics Welcomes Accomplished Biotechnology Leader Dr. Richard Glickman to its Board of Directors
numerous public and private biotechnology companies, including leadership roles as Chair of Aurinia Pharmaceuticals, ESSA Pharma, enGene, and has held board positions at Eupraxia Pharmaceuticals and Cardiome / Correvio Pharma, amongst others, where he helped scale emerging biotechnology companies into globally
More news about: Specific Biologics Inc.
Dec 16, 2025, 10:00 ET Lilly to participate in J.P. Morgan Healthcare Conference
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Dec 16, 2025, 08:46 ET Aces Diagnostics Announces Key Development Partnerships for Novel LymeSeek™ Test
PHOENIX, Dec. 16, 2025 /PRNewswire/ -- Aces Diagnostics Inc., a biotechnology company dedicated to delivering accurate and accessible diagnostics for Lyme disease, announced significant progress toward commercialization of
More news about: Aces Diagnostics
Dec 16, 2025, 08:30 ET Allink Biotherapeutics Completes $47M Extension Rounds of Series A to Accelerate Clinical Programs and Novel Platforms Development
SHANGHAI, Dec. 16, 2025 /PRNewswire/ -- Allink Biotherapeutics, Inc. (AllinkBio), a clinical-stage biotechnology company focusing on developing advanced antibody-drug conjugates (ADCs) and multi-specific antibody therapeutics for oncology and immunology, today
More news about: Allink Biotherapeutics
Dec 16, 2025, 08:30 ET Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities
Roche Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics
More news about: Roche Diagnostics
Dec 16, 2025, 08:30 ET Amorphical Announces Positive Final Long-Term Results from Phase 2 Crohn's Disease Trial: Results Confirm Efficacy and Show Sustained Clinical Remission
190 patents.About AmorphicalAmorphical is a biotechnology company advancing a new class of nano-amorphous mineral pharmacologic agents. Leveraging a proprietary, nature-inspired platform, Amorphical aims
More news about: Amorphical
Dec 16, 2025, 08:15 ET Avant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes Treatment
Dec. 16, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging biotechnology company focused on developing cell-based therapies for diabetes and age-related disorders, today highlights the essential importance of cell encapsulation
More news about: Avant Technologies Inc.
Dec 16, 2025, 08:06 ET Ambros Therapeutics Launches with $125 Million Series A Financing to Advance Neridronate Through Phase 3 Registrational Program for Complex Regional Pain Syndrome Type 1
Calif., Dec. 16, 2025 /PRNewswire/ -- Ambros Therapeutics, Inc. today announced its launch as a clinical-stage biotechnology company advancing late-stage therapies for severe, underserved diseases beginning with neridronate for Complex Regional Pain Syndrome Type 1 (CRPS-1).
More news about: Ambros Therapeutics
Dec 16, 2025, 07:30 ET REZOLVE-AA Phase 2b Study of Rezpegaldesleukin Establishes Proof-of-Concept in Patients with Severe-to-Very-Severe Alopecia Areata
SAN FRANCISCO, Dec. 16, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on development of novel immunology therapies, today announced topline results from the 36-week induction treatment period of the
More news about: Nektar Therapeutics
Dec 16, 2025, 05:31 ET BPC Instruments partners with SixRing to provide quality assurance for the EU and UK biomethane markets
instruments enabling more efficient, reliable, and higher quality research and analysis for industries in renewable bioenergy and environmental biotechnology. The result is not only higher accuracy and precision, but also a significant reduction in time consumption and labor requirement for performing
More news about: BPC Instruments AB
Dec 16, 2025, 02:30 ET Allink Biotherapeutics Completes $47M Extension Rounds of Series A to Accelerate Clinical Programs and Novel Platforms Development
SHANGHAI, Dec. 16, 2025 /PRNewswire/ -- Allink Biotherapeutics, Inc. (AllinkBio), a clinical-stage biotechnology company focusing on developing advanced antibody-drug conjugates (ADCs) and multi-specific antibody therapeutics for oncology and immunology, today
More news about: Allink Biotherapeutics
Dec 16, 2025, 02:00 ET Hamilton Launches GlucoSense, a First-of-Its-Kind, Real-Time, In Situ Glucose Sensor for Mammalian Cell Culture
devices, process sensors, consumables, and OEM liquid handling solutions.Known for advancing the life science, clinical diagnostics, forensics, biotechnology and biopharma industries, Hamilton products offer reliability, performance, and flexibility. Hamilton utilizes state-of-the-art manufacturing at
More news about: Hamilton Company
Dec 15, 2025, 18:00 ET Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Induction Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on December 16, 2025
SAN FRANCISCO, Dec. 15, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on development of novel immunology therapies, today announced it will host an investor call and live webcast to review topline results
More news about: Nektar Therapeutics
Dec 15, 2025, 16:30 ET The Inner Circle acknowledges, Melvin Colón as a Pinnacle Professional Member Inner Circle of Excellence
bringing new medical products to market. Mr. Colón is a licensed chemist with a proven track record of success across the pharmaceutical, biotechnology, including cell and gene therapy, biosimilars, and medical device industries, including combination products. His expertise includes Quality Assurance
More news about: The Inner Circle
Dec 15, 2025, 16:01 ET Kodiak Sciences Announces Proposed Public Offering of Common Stock
Calif., Dec. 15, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, today announced that it has commenced an underwritten
More news about: Kodiak Sciences Inc.
Dec 15, 2025, 14:58 ET Roche receives FDA approval for first diagnostic tests to identify HER2-positive metastatic breast cancer patients eligible for ENHERTU
RocheFounded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics
More news about: Roche
Dec 15, 2025, 13:45 ET BioFlorida Fuels Innovation: Awards $90,000 in Annual Pitch Competition
progressive multiple sclerosis and ALS, with FDA clearance to move forward with advanced trial studies.Asha Therapeutics, a Tampa based biotechnology company, earned $30,000 as the Emerging Florida winner for their pioneering therapeutic platform. Under the leadership of Co-founder, Chief Scientific
More news about: BioFlorida
Dec 15, 2025, 09:15 ET LifeNet Health Advances Regenerative Medicine with the Acquisition of Biopreservation Leader, Tissue Testing Technologies
15, 2025 /PRNewswire/ -- LifeNet Health, a global leader in regenerative medicine, has acquired Tissue Testing Technologies LLC (T3), a biotechnology company specializing in biopreservation. T3 's advanced proprietary technologies and services preserve living cells and tissues for clinical and
More news about: LifeNet Health
Dec 15, 2025, 09:05 ET Pivot Bio Announces Additions to Senior Management
contributed to multiple insect-control biotechnology products in North and South America, including Trecepta, SmartStaxPro, Intacta, BollGard and ThryvOn for corn, soy and cotton, respectively. He held several leadership roles across R&D in regulatory as well as biotechnology product development organizations. Prior
More news about: Pivot Bio, Inc
Dec 15, 2025, 08:45 ET Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has completed the transfer of the Investigational New Drug application
More news about: Anixa Biosciences, Inc.
Dec 15, 2025, 08:30 ET Leucid Bio and Syenex Announce Strategic Collaboration for In Vivo CAR-T Cell Engineering
and CHICAGO, Dec. 15, 2025 /PRNewswire/ -- Leucid Bio ("Leucid" or the "Company"), a privately-held biotechnology company developing innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies using its proprietary lateral CAR platform, and Syenex, an open-science
More news about: Leucid Bio
Dec 15, 2025, 08:30 ET Link Cell Therapies Launches with Vision of Advancing CAR-T Therapies in Solid and Liquid Tumors
[email protected] Link Cell Therapies Link Cell Therapies ("Link") is a biotechnology company based in South San Francisco, California that was founded in 2022 by Robbie Majzner, MD and Crystal Mackall, MD at Stanford University.
More news about: Link Cell Therapies
Dec 15, 2025, 08:00 ET Diakonos Oncology to Present Corporate Overview and Participate in Panel at 2026 Biotech Showcase
clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today announced it will participate in the Biotech Showcase in San Francisco, CA, from January 13-15, 2026. This premier event is for private and micro-mid-cap biotechnology companies
More news about: Diakonos Oncology
Dec 15, 2025, 08:00 ET Leadgene Biosolutions, Inc., (Formerly CYTENA BPS), Announces Corporate Rebranding to Mark a New Phase of Growth within the Leadgene Group
Biosolutions, Inc. (formerly CYTENA BPS), following its transition out of the BICO Group, now officially integrates with Leadgene Biomedical, a biotechnology company specializing in recombinant proteins, antibodies, and diagnostic reagent development with integrated CRO/CDMO services. This alignment enables
More news about: Leadgene Biosolutions